Secreted frizzled-related protein 4 reduces insulin secretion and is overexpressed in type 2 diabetes.
about
CFTR and Anoctamin 1 (ANO1) contribute to cAMP amplified exocytosis and insulin secretion in human and murine pancreatic beta-cellsIslet inflammation: a unifying target for diabetes treatment?Identification of co-expression gene networks, regulatory genes and pathways for obesity based on adipose tissue RNA Sequencing in a porcine modelInsulin biosynthetic interaction network component, TMEM24, facilitates insulin reserve pool releaseSox5 regulates beta-cell phenotype and is reduced in type 2 diabetesA phospho-BAD BH3 helix activates glucokinase by a mechanism distinct from that of allosteric activatorsHepatic, adipocyte, enteric and pancreatic hormones: response to dietary macronutrient composition and relationship with metabolism.Global genomic and transcriptomic analysis of human pancreatic islets reveals novel genes influencing glucose metabolismReversal of β cell de-differentiation by a small molecule inhibitor of the TGFβ pathway.Genome-wide associations between genetic and epigenetic variation influence mRNA expression and insulin secretion in human pancreatic islets.Association of secreted frizzled-related protein 4 (SFRP4) with type 2 diabetes in patients with stable coronary artery diseaseSex differences in the genome-wide DNA methylation pattern and impact on gene expression, microRNA levels and insulin secretion in human pancreatic islets.β-Cell inflammation in human type 2 diabetes and the role of autophagy.Mice deficient in Sfrp1 exhibit increased adiposity, dysregulated glucose metabolism, and enhanced macrophage infiltrationPathway Analysis of Metabolic Syndrome Using a Genome-Wide Association Study of Korea Associated Resource (KARE) Cohorts.Wnt antagonist secreted frizzled-related protein 4 upregulates adipogenic differentiation in human adipose tissue-derived mesenchymal stem cells.Integrative enrichment analysis: a new computational method to detect dysregulated pathways in heterogeneous samples.Sulforaphane reduces hepatic glucose production and improves glucose control in patients with type 2 diabetes.Current concepts regarding developmental mechanisms in diabetic retinopathy in Taiwan.Genome-wide DNA methylation profiles changes associated with constant heat stress in pigs as measured by bisulfite sequencing.Up-regulation of miR-98 and unraveling regulatory mechanisms in gestational diabetes mellitus.Molecular phenotyping of multiple mouse strains under metabolic challenge uncovers a role for Elovl2 in glucose-induced insulin secretion.Toll-like receptors and NLRP3 as central regulators of pancreatic islet inflammation in type 2 diabetes.Type 2 diabetes mellitus: From a metabolic disorder to an inflammatory condition.Islet inflammation in type 2 diabetes.Platelet-derived miR-103b as a novel biomarker for the early diagnosis of type 2 diabetes.Anti-cancer properties of olive oil secoiridoid phenols: a systematic review of in vivo studies.Downregulation of Sfrp5 promotes beta cell proliferation during obesity in the rat.Altered levels of circulating cytokines and microRNAs in lean and obese individuals with prediabetes and type 2 diabetes.Pancreatic Beta Cell Identity in Humans and the Role of Type 2 Diabetes.Differential Activation of Innate Immune Pathways by Distinct Islet Amyloid Polypeptide (IAPP) Aggregates.Further evidence of the involvement of the Wnt signaling pathway in Dupuytren's disease.IL-1 mediates amyloid-associated islet dysfunction and inflammation in human islet amyloid polypeptide transgenic mice.Optogenetic Control of Pancreatic Islets.Human epicardial adipose tissue-derived and circulating secreted frizzled-related protein 4 (SFRP4) levels are increased in patients with coronary artery disease.Thrombin stimulates insulin secretion via protease-activated receptor-3Variants of GSK3β and SFRP4 genes in Wnt signaling were not associated with osteonecrosis of the femoral head.Computer aided screening of secreted frizzled-related protein 4 (SFRP4): a potential control for diabetes mellitus.Type 2 diabetes mellitus--an autoimmune disease?Pancreatic β-Cell Electrical Activity and Insulin Secretion: Of Mice and Men.
P2860
Q24298624-4E9A9A40-ED31-44B1-9D53-C587966B3FCCQ26860847-F0DF9F70-F69B-4C97-BF68-C323A362530BQ28248944-C636E59C-4913-4366-BC38-B6FBC17E4D00Q28584801-0206BD91-17E9-4846-BCC7-19ADCA48C1C9Q33786322-AA63F690-A5CD-4C49-BA86-B1439A0DEBE9Q33855651-3D736CE5-3B0D-4753-B124-D6105953F109Q33877081-EC34D976-9397-4B89-8617-2C502B70E209Q34281205-BD03CAE4-49FF-4FB1-8150-25624C300CA2Q34378230-AABCFADC-3C38-41B2-BDB4-FD8808477EC2Q34464568-095F75AA-5B1D-4E12-A4B7-B16FB8025083Q34586921-53D9FD38-D72C-423C-BF3F-92C42772D9E0Q34636586-D0C2C416-F2DD-4001-AB36-C9F37200AC35Q34977998-A0414A8E-42A3-446B-B46B-605E55CEA610Q35067279-23B73058-CED6-463C-AE69-FBE807212DA0Q35088695-4E2D3448-4F05-4A27-93D3-EF41FC535476Q35567511-4C2794C9-1712-4CF3-841D-2012C998AC6CQ35837792-A43BCA09-5074-40F9-83F2-E1F5C907869FQ36405748-970D7B50-41A1-42BD-9653-4280A8376927Q36877327-A5974BFA-EA7E-4270-8E48-CAEA5F9E774CQ36970703-A74349D7-719B-47E6-B241-40396C51BBFEQ37215843-FA683F83-CF9B-404D-B621-AA36C35BDA4AQ37724749-D16E5E12-FE24-4891-9C16-C3500263754FQ38184888-515B978F-3F84-452A-AA49-E7F85C1C9D67Q38490628-AFA531EC-133A-480B-B2CA-6D6E66A69CA3Q38740642-5280BB0A-2AC7-447F-A4FE-70B47B84CAA7Q38893517-CE29F6B8-ADE2-46A8-8DEA-FB35A372AAC4Q38974537-4ED6D54B-4129-4A0E-8B3E-CE55A75A433FQ39100118-88C9BF75-B5E0-453B-A97E-43A5F00865B8Q39168772-B410AEF5-2CA4-4DF8-BB38-C2B271DD12B2Q39355916-7F19A60B-1BBE-442F-B804-52A04BE51DB5Q40087596-B9A1CC43-CAB7-472B-86A5-D263672C6322Q40784686-DA8D0271-25E2-41D8-A766-19653BADF9A1Q41710782-96CFF762-823E-456E-98CF-3FCD8C8C4E9BQ42116904-52AEAC04-C2FB-45AE-A688-36C16F9CF5FAQ42379235-ABB604E3-CC01-4814-98BE-D00B6270E6BCQ42567801-5C20391A-722B-4EB7-9E6F-5DE90D2FABB5Q42654036-D2E0DB21-460A-49FF-8E81-E8B8B4080F63Q42704850-DD9B7A05-45F0-4A87-B063-18D7EA6D4B46Q46799317-99625A98-7DB3-4F23-B351-8EF124ED14ACQ47322426-E4D74CBA-12B3-4F44-94C4-C56999F898FD
P2860
Secreted frizzled-related protein 4 reduces insulin secretion and is overexpressed in type 2 diabetes.
description
2012 nî lūn-bûn
@nan
2012 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Secreted frizzled-related prot ...... rexpressed in type 2 diabetes.
@ast
Secreted frizzled-related prot ...... rexpressed in type 2 diabetes.
@en
Secreted frizzled-related prot ...... rexpressed in type 2 diabetes.
@nl
type
label
Secreted frizzled-related prot ...... rexpressed in type 2 diabetes.
@ast
Secreted frizzled-related prot ...... rexpressed in type 2 diabetes.
@en
Secreted frizzled-related prot ...... rexpressed in type 2 diabetes.
@nl
prefLabel
Secreted frizzled-related prot ...... rexpressed in type 2 diabetes.
@ast
Secreted frizzled-related prot ...... rexpressed in type 2 diabetes.
@en
Secreted frizzled-related prot ...... rexpressed in type 2 diabetes.
@nl
P2093
P50
P921
P1433
P1476
Secreted frizzled-related prot ...... rexpressed in type 2 diabetes.
@en
P2093
Anders H Rosengren
Annika S Axelsson
Claes B Wollheim
Erik Renström
Jonathan Derry
Peter Almgren
Sarheed J Muhammed
Sonja Hänzelmann
Taman Mahdi
Ulrika Krus
P304
P356
10.1016/J.CMET.2012.10.009
P50
P577
2012-11-01T00:00:00Z